Radiologic screening of high-risk adults reduces lung-cancer-related mortality 1 , 2 ; however,
a small minority of eligible individuals undergo such screening in the United States 3 , 4 . …

Our study provides direct evidence for recurrent genetic aberrations preceding FL diagnosis,
revealing the combination of BCL2 translocation with CREBBP KAT domain mutations as …

Circulating tumor-derived DNA (ctDNA) is an emerging biomarker for many cancers, but the
limited sensitivity of current detection methods reduces its utility for diagnosing minimal …

Profiling of circulating tumor DNA (ctDNA) in the bloodstream shows promise for noninvasive
cancer detection. Chromatin fragmentation features have previously been explored to infer …

Most relapsed/refractory large B cell lymphoma (r/rLBCL) patients receiving anti-CD19
chimeric antigen receptor (CAR19) T cells relapse. To characterize determinants of resistance, …

This study shows that utDNA can be detected using HTS with high sensitivity and specificity
in patients with early-stage bladder cancer and during post-treatment surveillance, …

Background & Aims Biomarkers are needed to risk stratify after chemoradiotherapy for
localized esophageal cancer. These could improve identification of patients at risk for cancer …

In a large cohort of patients with B-cell lymphoma, time since anti-CD20 treatment was an
independent predictor of neutralizing antibody response to COVID-19 vaccination. Comparing …

The scarcity of malignant Hodgkin and Reed–Sternberg cells hampers tissue-based
comprehensive genomic profiling of classic Hodgkin lymphoma (cHL). By contrast, liquid biopsies …

Molecular monitoring of tumor-derived alterations has an established role in the surveillance
of leukemias, and emerging nucleic acid sequencing technologies are likely to similarly …